THOMAS FREEMAN, MD
Medical Practice at Bruce B Downs Blvd, Tampa, FL

License number
Florida ME53506
Category
Medical Practice
Type
Neurological Surgery
Address
Address 2
12901 Bruce B Downs Blvd, Tampa, FL 33612
PO Box 917770, Orlando, FL 32891
Phone
(813) 259-0889
(813) 259-0944 (Fax)

Personal information

See more information about THOMAS FREEMAN at radaris.com
Name
Address
Phone
Thomas Freeman
513 Westview Rd, Largo, FL 33770
Thomas Freeman
5230 Bone Ln, Brooksville, FL 34604
Thomas Freeman
526 Greenway Dr, Lake Wales, FL 33898
Thomas Freeman
4666 Watson St, Marianna, FL 32446
Thomas Freeman
4737 N Pine Hills Rd APT 910, Orlando, FL 32808

Organization information

See more information about THOMAS FREEMAN at bizstanding.com

Thomas Freeman MD,FACS

4 Columbia Dr, Tampa, FL 33606

Industry:
Neurosurgeon
Phone:
(813) 259-0929 (Phone)
Thomas Benedict Freeman

Professional information

See more information about THOMAS FREEMAN at trustoria.com
Thomas Freeman Photo 1
Dr. Thomas Freeman, Tampa FL - MD (Doctor of Medicine)

Dr. Thomas Freeman, Tampa FL - MD (Doctor of Medicine)

Specialties:
Neurosurgery
Address:
University South FL Medical Grp
2 Tampa General Cir, Tampa 33606
(813) 974-2201 (Phone)
University South FL Medical Grp
2 Tampa General Cir, Tampa 33606
(813) 974-2201 (Phone)
Certifications:
Neurosurgery, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1981
Columbia Presby Med Center
Graduated: 1982
Nyu Med Center
Graduated: 1988


Thomas Benedict Freeman Photo 2
Thomas Benedict Freeman, Tampa FL

Thomas Benedict Freeman, Tampa FL

Specialties:
Neurosurgeon
Address:
12901 Bruce B Downs Blvd, Tampa, FL 33612
2 Tampa General Circle, Tampa, FL 33606
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery


Thomas Freeman Photo 3
Proliferated Cell Lines And Uses Thereof

Proliferated Cell Lines And Uses Thereof

US Patent:
7416885, Aug 26, 2008
Filed:
Feb 7, 2003
Appl. No.:
10/359854
Inventors:
Thomas B. Freeman - Tampa FL, US
Pablo Caviedes - Santiago, CL
Raul Caviedes - Santiago, CL
Assignee:
University of South Florida - Tampa FL
University of Chile
International Classification:
C12N 5/00
US Classification:
435325
Abstract:
The subject invention pertains to tumor cell lines useful for increasing the proliferation potential of any human or animal cell in culture, thereby providing immortalized or continuous cell lines and cultures. The invention also concerns proliferation factors, and compositions containing the factors, which are capable of increasing the proliferation potential of any human or other animal cell in culture. The subject invention further pertains to a method for proliferation cells in culture by contacting cells with the proliferation factors. The proliferated cells can range in plasticity and can include, for example, blast cells, fertilized ova, non-fertilized gametes, embryonic stem cells, adult stem cells, precursor or progenitor cells, and highly specialized cells. Optionally, the cells can be induced to cease proliferation. The proliferation cells of the subject invention are useful for cell therapy, cell/gene therapy, biological production of molecules, and as in vitro models for research, toxicity testing, and drug development.


Thomas Freeman Photo 4
Asymmetric Disc Distracting Cage

Asymmetric Disc Distracting Cage

US Patent:
2010015, Jun 17, 2010
Filed:
Mar 1, 2010
Appl. No.:
12/714990
Inventors:
Thomas B. Freeman - Tampa FL, US
Wesley Johnson - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61F 2/44
US Classification:
623 1716
Abstract:
An inter-vertebral cage with a wedge shape eccentrically located on the leading end of the cage. The ectopically shaped leading edge of this embodiment facilitates easier interbody spacer placement with less risk of nerve injury, as well as with likely decreased risk of destruction of the end plate during the distraction process when the interbody cage is impacted.


Thomas Freeman Photo 5
Bone Marrow-Derived Neuronal Cells

Bone Marrow-Derived Neuronal Cells

US Patent:
2008020, Aug 28, 2008
Filed:
Dec 12, 2007
Appl. No.:
11/954473
Inventors:
Juan Sanchez-Ramos - Tampa FL, US
Shijie Song - Tampa FL, US
William Janssen - Tampa FL, US
Paul Sanberg - Spring Hill FL, US
Thomas Freeman - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61K 35/12, C12N 5/08, A61P 25/16, C12N 5/06
US Classification:
424 937, 435368, 435383, 435375
Abstract:
Bone marrow stromal cells (BMSC) differentiate into neuron-like phenotypes in vitro and in vivo, engrafted into normal or denervated rat striatum. The BMSC administered into the ventricle did not remain localized to the site of the graft, but migrated throughout the brain and integrated into specific brain regions in various architectonic patterns. The most orderly integration of BMSC was in the laminar distribution of cerebellar Purkinje cells, where the BMSC-derived cells took on the Purkinje phenotype. The BMSC exhibited site-dependent differentiation and expressed several neuronal markers including neuron-specific nuclear protein, tyrosine hydroxylase and calbindin. Treated BMSC implanted intrastriatally stayed in the cortex and the striatum, produced tyrosine hydroxylase which produces the dopamine needed in Parkinson's disease.


Thomas Freeman Photo 6
Methods For Cell Therapy

Methods For Cell Therapy

US Patent:
8252279, Aug 28, 2012
Filed:
Dec 6, 2007
Appl. No.:
11/951529
Inventors:
Pablo Caviedes - Santiago, CL
Raul Caviedes - Santiago, CL
Thomas B. Freeman - Tampa FL, US
Juan A. Asenjo - Santiago, CL
Barbara A. Andrews - Santiago, CL
Dario SepĂșlveda - Santiago, CL
Christian Arriagada - Santiago, CL
Julio Salazar Rivera - Santiago, CL
Assignee:
University of South Florida - Tampa FL
International Classification:
C12N 5/02
US Classification:
424 937, 435383, 435368
Abstract:
The subject invention pertains to materials and methods for inhibiting process formation and extension by cells in culture. The subject invention further includes cultures of process-forming cells wherein formation and extension of processes have been inhibited. In another aspect, the subject invention concerns methods of transplantation using process-forming cells that have been cultured by the process-inhibiting methods of the invention.


Thomas Freeman Photo 7
Bone Marrow-Derived Neuronal Cells

Bone Marrow-Derived Neuronal Cells

US Patent:
2006019, Aug 31, 2006
Filed:
Jan 27, 2003
Appl. No.:
10/353742
Inventors:
Juan Sanchez-Ramos - Tampa FL, US
Shijie Song - Tampa FL, US
William Janssen - Tampa FL, US
Paul Sanberg - Spring Hill FL, US
Thomas Freeman - Tampa FL, US
International Classification:
A61K 35/30, C12N 5/08
US Classification:
435368000, 424093700
Abstract:
Bone marrow stromal cells (BMSC) differentiate into neuron-like phenotypes in vitro and in vivo, engrafted into normal or denervated rat striatum. The BMSC did not remain localized to the site of the graft, but migrated throughout the brain and integrated into specific brain regions in various architectonic patterns. The most orderly integration of BMSC was in the laminar distribution of cerebellar Purkinje cells, where the BMSC-derived cells took on the Purkinje phenotype. The BMSC exhibited site-dependent differentiation and expressed several neuronal markers including neuron-specific nuclear protein, tyrosine hydroxylase and calbindin. BMSC can be used to target specific brain nuclei in strategies of neural repair and gene therapy.


Thomas Freeman Photo 8
Materials And Methods For Regulating Process Formation In Cell Culture

Materials And Methods For Regulating Process Formation In Cell Culture

US Patent:
7323333, Jan 29, 2008
Filed:
Mar 31, 2004
Appl. No.:
10/815388
Inventors:
Pablo Caviedes - Santiago, CL
Raul Caviedes - Santiago, CL
Thomas B. Freeman - Tampa FL, US
Juan A. Asenjo - Santiago, CL
Barbara A. Andrews - Santiago, CL
Dario SepĂșlveda - Santiago, CL
Christian Arriagada - Santiago, CL
Julio Salazar Rivera - Santiago, CL
Assignee:
University of South Florida - Tampa FL
University of Chile
International Classification:
C12N 5/08
US Classification:
435368, 435325, 435366, 435383
Abstract:
The subject invention pertains to materials and methods for inhibiting process formation and extension by cells in culture. The subject invention further includes cultures of process-forming cells wherein formation and extension of processes have been inhibited. In another aspect, the subject invention concerns methods of transplantation using process-forming cells that have been cultured by the process-inhibiting methods of the invention.


Thomas Freeman Photo 9
Method Of Treating Herpes Virus Infections

Method Of Treating Herpes Virus Infections

US Patent:
2004010, Jun 10, 2004
Filed:
Aug 1, 2003
Appl. No.:
10/604591
Inventors:
Thomas Freeman - Tampa FL, US
G. Nauert - Tarpon Springs FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61K039/205
US Classification:
424/224100
Abstract:
The present invention is a novel alternative use of the rabies vaccine for the purposes of suppressing herpes outbreaks.


Thomas Freeman Photo 10
Putamen Grid

Putamen Grid

US Patent:
8012159, Sep 6, 2011
Filed:
May 20, 2005
Appl. No.:
10/908648
Inventors:
Thomas B. Freeman - Tampa FL, US
James P. O'Connor - Billerica MA, US
Assignee:
University of South Florida - Tampa FL
International Classification:
A61B 19/00
US Classification:
606130
Abstract:
The present invention makes a grid array, for use in the transplantation of materials into the brain, in the shape of a predetermined structure, such as the putamen, based on anatomic analysis the structure. Alternatively, a smaller grid array is used which only includes the putamen target and not the caudate target, and also has two windows within the grid array. Because of the smaller size of this grid array as well as the two cutouts in the middle, it is possible for the first time to observe the brain as the needle enters the brain through the grid array. The previous solid and larger grid array made the passage of the needle into the brain a blind maneuver. Therefore if there was cortical bleeding at the time of needle insertion, it would not be known until after the transplant was done.